Strategies such as localisation as well as premiumisation and an entrepreneurial work culture have enabled HUL become the fifth most valuable company in BT 500.
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.
The oil explorer burnt cash to buy HPCL, pay large dividend and is now being pushed for a share buyback to help meet the governments disinvestment target. Can increase in crude oil prices rebuild market sentiment?